Assessment of depressive symptoms in patients with COVID-19 during the second wave of epidemic in Myanmar: A cross-sectional single-center study
- PMID: 34086722
- PMCID: PMC8177551
- DOI: 10.1371/journal.pone.0252189
Assessment of depressive symptoms in patients with COVID-19 during the second wave of epidemic in Myanmar: A cross-sectional single-center study
Abstract
Background: Coronavirus disease 2019 (COVID-19) pandemic has had a great impact on every aspect of society. All countries launched preventive measures such as quarantine, lockdown, and physical distancing to control the disease spread. These restrictions might effect on daily life and mental health. This study aimed to assess the prevalence and associated factors of depressive symptoms in patients with COVID-19 at the Treatment Center.
Methods: A cross-sectional telephone survey was carried out at Hmawbi COVID-19 Treatment Center, Myanmar from December 2020 to January 2021. A total of 142 patients with COVID-19 who met the criteria were invited to participate in the study. A pre-tested Center for Epidemiologic Studies Depression Scale (CES-D) was used as a tool for depressive symptoms assessment. Data were analyzed by using binary logistic regression to identify associated factors of depressive symptoms. Adjusted odds ratio (AOR) with a 95% confidence interval (CI) was computed to determine the level of significance with a p < 0.05.
Results: The prevalence of depressive symptoms in patients with COVID-19 was 38.7%, with the means (± standard deviation, SD) subscale of somatic symptom, negative effect, and anhedonia were 4.64 (±2.53), 2.51 (± 2.12), and 5.01 (± 3.26), respectively. The patients with 40 years and older (AOR: 2.99, 95% CI: 1.36-6.59), < 4 of household size (AOR: 3.45, 95% CI: 1.46-8.15), ≤ 400,000 kyats of monthly family income (AOR: 2.38, 95% CI: 1.02-5.54) and infection to family members (AOR: 4.18, 95% CI: 1.74-10.07) were significant associated factors of depressive symptoms.
Conclusion: The high prevalence of depressive symptoms, approximately 40%, was found in patients with COVID-19 in the Treatment Center. Establishments of psychosocial supports, providing psychoeducation, enhancing the social contact with family and friends, and using credible source of information related COVID-19 would be integral parts of mental health services in COVID-19 pandemic situation.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Prevalence and Associated Factors of Depressive Symptoms Among Mizan-Tepi University Students During the COVID-19 Pandemic.J Racial Ethn Health Disparities. 2023 Apr;10(2):633-643. doi: 10.1007/s40615-022-01251-4. Epub 2022 Jan 28. J Racial Ethn Health Disparities. 2023. PMID: 35089580 Free PMC article.
-
Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic.JAMA Netw Open. 2020 Jul 1;3(7):e2014053. doi: 10.1001/jamanetworkopen.2020.14053. JAMA Netw Open. 2020. PMID: 32609353 Free PMC article.
-
Exploring depressive symptoms and its associates among Bangladeshi older adults amid COVID-19 pandemic: findings from a cross-sectional study.Soc Psychiatry Psychiatr Epidemiol. 2021 Aug;56(8):1487-1497. doi: 10.1007/s00127-021-02052-6. Epub 2021 Mar 4. Soc Psychiatry Psychiatr Epidemiol. 2021. PMID: 33661353 Free PMC article.
-
Factors Associated With Mental Health Disorders Among University Students in France Confined During the COVID-19 Pandemic.JAMA Netw Open. 2020 Oct 1;3(10):e2025591. doi: 10.1001/jamanetworkopen.2020.25591. JAMA Netw Open. 2020. PMID: 33095252 Free PMC article.
-
Geographic Distribution of Mental Health Problems Among Chinese College Students During the COVID-19 Pandemic: Nationwide, Web-Based Survey Study.J Med Internet Res. 2021 Jan 29;23(1):e23126. doi: 10.2196/23126. J Med Internet Res. 2021. PMID: 33439853 Free PMC article.
Cited by
-
Prevalence and Associated Factors of Depressive Symptoms Among Mizan-Tepi University Students During the COVID-19 Pandemic.J Racial Ethn Health Disparities. 2023 Apr;10(2):633-643. doi: 10.1007/s40615-022-01251-4. Epub 2022 Jan 28. J Racial Ethn Health Disparities. 2023. PMID: 35089580 Free PMC article.
-
Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review.BMC Infect Dis. 2021 Aug 2;21(1):729. doi: 10.1186/s12879-021-06409-9. BMC Infect Dis. 2021. PMID: 34340682 Free PMC article.
-
The Impact of Stress from Social Isolation during the COVID-19 Pandemic on Psychiatric Disorders: An Analysis from the Scientific Literature.Brain Sci. 2023 Oct 5;13(10):1414. doi: 10.3390/brainsci13101414. Brain Sci. 2023. PMID: 37891783 Free PMC article. Review.
-
Predicting Anxiety and Depression Among Patients With COVID-19 in Concentrated Isolation at Medical Camps in Vietnam: A Descriptive Cross-Sectional Study.Front Psychiatry. 2022 May 31;13:823586. doi: 10.3389/fpsyt.2022.823586. eCollection 2022. Front Psychiatry. 2022. PMID: 35711583 Free PMC article.
-
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics.Pharmaceutics. 2022 Feb 11;14(2):398. doi: 10.3390/pharmaceutics14020398. Pharmaceutics. 2022. PMID: 35214130 Free PMC article. Review.
References
-
- World Health Organization. Timeline of WHO’s response to COVID-19 Geneva: World Health Organization; 2020. [updated 2020 September 9; cited 2020 October 14]. Available from: https://www.who.int/news/item/29-06-2020-covidtimeline.
-
- World Health Organization. Coronavirus Disease (COVID-19) Dashboard Geneva, Switzerland: World Health Organization; 2020. [cited 2021 January 29]. Available from: https://covid19.who.int/.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous